NeueHealth outperforms competitors in upside potential, P/E ratio, and institutional ownership.
NeueHealth (NEUE), a publicly-traded company in the "Hospital & medical service plans" industry, is compared to its 13 competitors based on dividends, earnings, profitability, valuation, analyst recommendations, risk, and institutional ownership. NeueHealth has a higher potential upside of 30.93% compared to the sector's 15.39%. It has a lower price-to-earnings ratio and 63.9% of its shares held by institutional investors. Analysts suggest NeueHealth is more favorable than competitors.
April 28, 2024
4 Articles